For the Inventor, By the Inventor

Enter assignee name

South San Francisco, CA, United States of America

Genetech, Inc.

USPTO Granted Patents = 98

CIPO Patents = 3

Forward Citations = 2,491

Loading Chart...

Loading Chart...

288 inventors (with patents filed for the assignee):

Austin L Gurney (24 out of 719 patents)

Paul J Godowski (23 out of 594 patents)

William I Wood (22 out of 667 patents)

4. Audrey Goddard (21 out of 632 patents)

5. Victoria Smith (11 out of 312 patents)

6. Colin K Watanabe (9 out of 213 patents)

7. Kenneth J Hillan (7 out of 65 patents)

8. Luc Roland Desnoyers (6 out of 141 patents)

9. Napoleone Ferrara (6 out of 104 patents)

10. Margaret Ann Roy (6 out of 56 patents)

11. Daniel Tumas (6 out of 68 patents)

12. P Mickey Williams (5 out of 40 patents)

13. David Botstein (5 out of 60 patents)

14. J Christopher Grimaldi (5 out of 145 patents)

15. Timothy Andrew Stewart (4 out of 61 patents)

Core Competencies:

Cystine Knot Scaffold

VEGF Antibody Conjugates

Heteroaryl Pyridone Compounds

Anti-HtrA1 Antibodies

Multispecific Antibodies

Serine/Threonine Kinase Inhibitors

Benzoxepin PI3K Inhibitors

Anthracycline Derivative Conjugates

Nucleic Acid Molecules

Neuropilin Antagonists

Anti-CD79B Antibodies

Cysteine Engineered Antibodies

98 patents: Sort by Forward Citations

1. 11407794 - Cystine knot scaffold platform (2022-08-09),

2. 11111291 - Conjugates comprising a vascular endothelial growth factor (VEGF) antibody and a hyaluronic acid polymer (2021-09-07),

3. RE48239 - Heteroaryl pyridone and aza-pyridone compounds (2020-10-05),

4. 10450379 - Method for treating joint damage (2019-10-22),

5. 10421822 - Anti-HtrA1 antibodies and methods of use thereof (2019-09-24),

6. 10239861 - Therapeutic compounds and uses thereof (2019-03-26),

7. 9815904 - Pertuzumab variants and evaluation thereof (2017-11-14),

8. 9625462 - Elisa for VEGF (2017-04-18),

9. 9598481 - Anti-hemagglutinin antibodies and methods of use (2017-03-21),

10. 9409989 - Method for making multispecific antibodies having heteromultimeric and common components (2016-08-09),

11. 9388171 - Serine/threonine kinase inhibitors (2016-07-12),

12. 9315471 - Process of making hydroxylated cyclopentapyrimidine compounds and salts thereof (2016-04-19),

13. 9260425 - Pyrazolo[3,4-c]pyridine compounds and methods of use (2016-02-16),

14. 8975260 - Pyridazinones, method of making, and method of use thereof (2015-03-10),

15. 8952043 - Benzoxepin PI3K inhibitor compounds and methods of use (2015-02-10),

Genetech, Inc. is a leading biotechnology company that focuses on developing innovative solutions for healthcare. With a strong emphasis on research and development, Genetech is committed to improving the quality of life for patients around the world. Their portfolio includes groundbreaking therapies in the areas of oncology, immunology, and neurology.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

98 Patents

#12 in South San Francisco, CA

#876 in California

#3,714 in US

#7,675 in the World

South San Francisco, CA, United States of America

Genetech, Inc.

Forward Citations = 2,491

288 inventors:

Austin L Gurney (24 out of 719 patents)

Paul J Godowski (23 out of 594 patents)

William I Wood (22 out of 667 patents)

4. Audrey Goddard (21 out of 632 patents)

5. Victoria Smith (11 out of 312 patents)

Please report any incorrect information to support@idiyas.com

Loading…